Deutsch|English

Snri

Check interactions Compare

At a glance

Class

Not clearly classified yet

Pharmacological context

Mechanism

Mechanism is still being structured

Short read on known pharmacology

Interactions

7 documented

Curated visible combinations

Risk theme

6 high-risk interactions

Condensed from structured notes

Translation in progress

The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.

View German version

Overview

Detailed mechanism of action

Synapedia Evidence

Factual Snapshot

Risk level: Not classified
Source: https://synapedia.com/en/substances/snri

Frequently checked combinations

Important interactions with Snri

Check critical combinations first

MDMA + SNRIHigh riskClass-basedSerotonin syndrome risk from dual monoamine interferenceClass-based pair analysis

Interactions

Some entries are partly based on pharmacological classes. They are useful safety signals, but not fully substance-specific validation.

Some combinations can be dangerous. Research before combining substances. For breathing problems, unconsciousness, seizures, chest pain, high fever, or severe confusion, contact emergency services.

Dangerous

Maoi

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Gillman PK – MAOI interactions and serotonin toxicity Boyer EW & Shannon M – The serotonin syndrome

MDMA

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Gillman PK – Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity EMCDDA – MDMA Drug Profile

DMT

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Callaway JC & Grob CS – Ayahuasca pharmacology Stahl SM – SNRI pharmacology

5-MeO-DMT

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Sklerov J et al. – Death associated with 5-MeO-DMT Stahl SM – SNRI pharmacology

DXM

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

FDA Drug Safety Communication – Serotonin syndrome with DXM Boyer EW & Shannon M – Serotonin syndrome

All interactions

Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.

Frequently Asked Questions

What is the risk level of Snri?

The risk of Snri is not yet fully classified on Synapedia. There are 7 documented interactions with other substances. A complete risk assessment must consider context, dose, and potential combinations.

What are the most important interactions with Snri?

Special caution is warranted with the following combinations: Maoi, MDMA, DMT. These can significantly increase acute risks. The Synapedia Interaction Checker allows targeted pair-by-pair review.

This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.

Community signals & experiences

Signal hub →

Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.

These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.

The signal hub collects approved risk signals, experience reports and source leads by relevance.

Network

Full view

6 interactions

Some links may be class-based rather than substance-specific.

Trust Layer

How reliable this page currently is

Evidence, data quality, source base, and review status are condensed here for quick scanning.

Evidence level

Insufficient data

Insufficient data for reliable information. Page excluded from indexing.

Data quality

Baseline data

This page is still documented at a fairly rough level. Some statements may rely on class-level knowledge rather than deeper substance-specific coverage.

Baseline data / partly class-based

Parts of the assessment may be derived from substance classes, known mechanisms, or structured fallbacks.

Interaction notes may be pharmacological class warnings.
Not substance-specific clinical validation.
Sources and review status are being expanded.

Sources

No individual sources visible yet

No individual sources are visible right now. That means the assessment relies more heavily on internal curation and structural quality.

Review & freshness

Review status is being added

No visible review timestamp is available.

DraftFallback / baseline data

Completeness0%

Source depth0%

Freshness7%

Source-linked or marked as baseline data, not clinically reviewed and not medical advice.

View methodology

View in Knowledge Graph

Laden…

Interactions

Some entries are partly based on pharmacological classes. They are useful safety signals, but not fully substance-specific validation.

Some combinations can be dangerous. Research before combining substances. For breathing problems, unconsciousness, seizures, chest pain, high fever, or severe confusion, contact emergency services.

Dangerous

Maoi

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Gillman PK – MAOI interactions and serotonin toxicity Boyer EW & Shannon M – The serotonin syndrome

MDMA

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Gillman PK – Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity EMCDDA – MDMA Drug Profile

DMT

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Callaway JC & Grob CS – Ayahuasca pharmacology Stahl SM – SNRI pharmacology

5-MeO-DMT

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

Sklerov J et al. – Death associated with 5-MeO-DMT Stahl SM – SNRI pharmacology

DXM

Class warning

Dangerous interaction risk

Detailed interaction narrative is still being translated. This row shows the available risk level and data provenance only.

FDA Drug Safety Communication – Serotonin syndrome with DXM Boyer EW & Shannon M – Serotonin syndrome

All interactions

Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.

Frequently Asked Questions

What is the risk level of Snri?

What are the most important interactions with Snri?

Special caution is warranted with the following combinations: Maoi, MDMA, DMT. These can significantly increase acute risks. The Synapedia Interaction Checker allows targeted pair-by-pair review.

This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.